NATALIE MERCADO: Open Payments
NPI 1669779278 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 58 payments from 19 companies in 2025. Trend: 2023 $1,607 · 2024 $2,433 · 2025 $1,877
Food & beverage: $1,877
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 2 | $287 |
| Novartis Pharmaceuticals Corporation | 7 | $244 |
| GENZYME CORPORATION | 4 | $224 |
| Galderma Laboratories, L.P. | 7 | $217 |
| ABBVIE INC. | 6 | $200 |
| Kerecis Limited | 14 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $54 |
| Smith+Nephew, Inc. | 2 | $40 |
Products named: DUPIXENT, Zoryve, NEMLUVIO, Kerecis SurgiClose, RINVOQ, Rhapsido, SPEVIGO, SKYRIZI.
Industry payments across GA — which companies pay providers there.
